Approaches to environmental exposure assessment in children

V M Weaver, T J Buckley, J D Groopman, V M Weaver, T J Buckley, J D Groopman

Abstract

An improved understanding of the contribution made by environmental exposures to disease burden in children is essential, given current increasing rates of childhood illnesses such asthma and cancer. Children must be routinely included in environmental research. Exposure assessment, both external (e.g., air, water) and internal dose (e.g., biomarkers), is an integral component of such research. Biomarker measurement has some advantages that are unique in children. These include assessment of potentially increased absorption because of behaviors that differ from adults (i.e., hand-to-mouth activity); metabolite measurement, which can help identify age-related susceptibility differences; and improved assessment of dermal exposure, an important exposure route in children. Environmental exposure assessment in children will require adaption of techniques that are currently applied in adult studies as well as development of tools and validation of strategies that are unique for children. Designs that focus on parent-child study units provide adult comparison data and allow the parent to assist with more complex study designs. Use of equipment that is sized appropriately for children, such as small air pumps and badge monitors, is also important. When biomarkers are used, biologic specimens that can be obtained noninvasively are preferable. Although the current need is primarily for small focused studies to address specific questions and optimize research tools, the future will require establishment of large prospective cohorts. Urban children are an important study cohort because of relatively high morbidity observed in the urban environment. Finally, examples of completed or possible future studies utilizing these techniques are discussed for specific exposures such as benzene, environmental tobacco smoke, aflatoxin, volatile organic compounds, and polycyclic aromatic hydrocarbons.

References

    1. J Assoc Off Anal Chem. 1980 Sep;63(5):1077-104
    1. Am J Public Health. 1984 May;74(5):479-84
    1. Public Health Rev. 1985;13(1-2):1-54
    1. J Occup Med. 1986 Aug;28(8):593-602
    1. J Natl Cancer Inst. 1987 May;78(5):887-98
    1. Environ Health Perspect. 1989 Jul;82:165-9
    1. Regul Toxicol Pharmacol. 1989 Oct;10(2):123-37
    1. J Air Waste Manage Assoc. 1990 Jul;40(7):966-75
    1. Risk Anal. 1990 Dec;10(4):575-80
    1. Lancet. 1991 Jun 29;337(8757):1602
    1. Regul Toxicol Pharmacol. 1991 Dec;14(3):297-312
    1. Br J Ind Med. 1992 Feb;49(2):113-24
    1. Lancet. 1992 Apr 18;339(8799):943-6
    1. Carcinogenesis. 1992 May;13(5):891-4
    1. Am J Public Health. 1992 Jul;82(7):955-63
    1. Arch Environ Contam Toxicol. 1994 Jan;26(1):47-59
    1. Toxicol Ind Health. 1993 Sep-Oct;9(5):685-727
    1. Clin Pediatr (Phila). 1994 Apr;33(4):220-6
    1. J Chromatogr B Biomed Appl. 1995 Mar 24;665(2):271-9
    1. Int Arch Occup Environ Health. 1995;67(4):257-66
    1. Rev Environ Contam Toxicol. 1995;143:59-78
    1. Environ Health Perspect. 1995 Sep;103 Suppl 6:7-12
    1. J Expo Anal Environ Epidemiol. 1995 Jul-Sep;5(3):297-325
    1. Environ Health Perspect. 1996 Jan;104(1):48-51
    1. Cancer Epidemiol Biomarkers Prev. 1996 Feb;5(2):135-7
    1. Environ Health Perspect. 1996 Mar;104(3):318-23
    1. Environ Health Perspect. 1996 Oct;104 Suppl 5:861-9
    1. Environ Health Perspect. 1996 Oct;104 Suppl 5:927-32

Source: PubMed

3
订阅